These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 1108041)

  • 1. Effects of allogenic and effector cells on the development of antibody-producing cells, in vitro.
    Pazdernik TL; Uyeki DM
    Proc Soc Exp Biol Med; 1975 Dec; 150(3):654-9. PubMed ID: 1108041
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The potentiality of antibody-producing cells. I Bispecific cell occurrence in double stimulated cultures of syngeneic or allogeneic spleen cells of the mouse.
    Couderc J; Bleux C; Birrien JL; Liacopoulos P
    Immunology; 1975 Oct; 29(4):653-64. PubMed ID: 1102444
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Allogeneic suppression: inhibition of antibody plaque forming cells in vitro by non-sensitized lymphoid cells.
    Friedman H
    Transplant Proc; 1969 Mar; 1(1):574-6. PubMed ID: 4944273
    [No Abstract]   [Full Text] [Related]  

  • 4. The immune response of mice treated with anti-mu antibodies: the effect on antibody-forming cells, their precursors and helper cells assayed in vitro.
    Gordon J; Murgita RA; Tomasi TB
    J Immunol; 1975 Jun; 114(6):1808-12. PubMed ID: 805179
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effector cell blockade. A new mechanism of immune hyporeactivity induced by multivalent antigens.
    Schrader JW; Nossal GJ
    J Exp Med; 1974 Jun; 139(6):1582-98. PubMed ID: 4133616
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of the autoimmune plaque-forming cell response to single-strand DNA (sDNA) in vitro.
    Roder JC; Bell DA; Singhal SK
    J Immunol; 1978 Jul; 121(1):38-43. PubMed ID: 353196
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A study of the mechanism of Con A-induced immunosuppression in vivo.
    Smith SR; Umland S; Terminelli C; Watnick AS
    Cell Immunol; 1984 Aug; 87(1):147-58. PubMed ID: 6234994
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of delta9-tetrahydrocannabinol on in vitro sensitization of mouse splenic lymphocytes.
    Lefkowitz SS; Klager K
    Immunol Commun; 1978; 7(5):557-66. PubMed ID: 359460
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Negative allogeneic effects in vitro. I. Allogeneic T cells markedly suppress the secondary antibody-forming cell response.
    Swain SL; Dutton RW
    J Immunol; 1977 Jun; 118(6):2262-8. PubMed ID: 325144
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human natural killer-like activity against mouse spleen cells.
    Yamamoto JK; Blalock JE; Johnson HM
    Eur J Immunol; 1982 Mar; 12(3):222-7. PubMed ID: 7047174
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nonspecific elicitation of antibody-forming cells in the mouse spleen by bacterial lipopolysaccharide.
    Nakano M; Uchiyama T; Tanabe MJ; Saito K
    Jpn J Microbiol; 1975 Apr; 19(2):141-8. PubMed ID: 1097768
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sensitized (T6 X RFM)F1 donor B cells are engrafted and synthesize antibodies without further antigenic stimulation in RFM recipients with allogenic host-vs-graft disease.
    Hard RC; Carter WH; Bick PH
    J Immunol; 1983 Dec; 131(6):2623-9. PubMed ID: 6358351
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence of donor suppression of anti-donor PFC responses in mice.
    Taylor GM
    Clin Exp Immunol; 1975 Oct; 22(1):194-6. PubMed ID: 1240048
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence for multipotentiality of antibody synthesizing cells.
    Liacopoulos P; Couderc J; Bleux C
    Ann Immunol (Paris); 1976; 127(3-4):519-30. PubMed ID: 786144
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The potentiality of antibody-producing cells. II. Evidence for two antibody molecules of different specificities secreted by micromanipulated bispecific mouse spleen cells.
    Couderg J; Bleux C; Liacopoulos P
    Immunology; 1975 Oct; 29(4):665-74. PubMed ID: 52617
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro detection of anti-thyroglobulin antibody forming cells from the lymphocytes of chronic thyroiditis patients and analysis of their regulation.
    Noma T; Yata J; Shishiba Y; Inatsuki B
    Clin Exp Immunol; 1982 Sep; 49(3):565-71. PubMed ID: 6756721
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increase in the number of splenic plaque forming cells with length of gestation in untreated pregnant mice.
    Mattsson R
    Dev Comp Immunol; 1982; 6(2):339-48. PubMed ID: 7047249
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantification of in vitro antibody secretion by immune spleen cells.
    Van Dijk H; Bloksma N
    J Immunol Methods; 1977; 14(3-4):325-31. PubMed ID: 320270
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanism of effector cell blockade. III. The increased sensitivity of neonatal PFC to effector cell blockade.
    Boyd AW; Schrader JW
    Cell Immunol; 1982 Oct; 73(1):192-200. PubMed ID: 6217902
    [No Abstract]   [Full Text] [Related]  

  • 20. Genetic control of immune responses in vitro. II. Cellular requirements for the development of primary plaque-forming cell responses to the random terpolymer 1-glutamic acid 60-1-alanine30-1-tyrosine10 (GAT) by mouse spleen cells in vitro.
    Kapp JA; Pierce CW; Benacerraf B
    J Exp Med; 1973 Nov; 138(5):1121-32. PubMed ID: 4126767
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.